PGHH

Procter & Gamble Hygiene and Health Care share price & financials

Price
₹9,274.5
Market cap
₹24.4k Cr
Sector
Fast Moving Consumer Goods
Calls analysed
2
Latest concall · Q4 FY26 · call held 16 Jun 2026

P & G Hygiene Q4 FY26

PAT ₹850 cr +19%

What went well

  • Profit After Tax (PAT) grew 19% to ₹850 crores, demonstrating strong bottom-line performance.
  • Company achieved ₹86 crores in savings through targeted productivity and savings programs.
  • Whisper Period Pants, a new segment, sold 10 crore units in the last year, indicating successful innovation and market acceptance.

What to watch

  • Sales remained flat at ₹4300 crores versus the same period last year, indicating muted top-line growth.
  • Operating environment is dynamic and constantly evolving, with macro-economic context providing short-term headwinds.
Read the full call →

What Procter & Gamble Hygiene and Health Care Limited does

Procter & Gamble Hygiene and Health Care Limited manufactures and markets branded FMCG products in India across two categories: feminine care and health care. Its portfolio includes Whisper, India's leading feminine hygiene brand, and Vicks, India's No. 1 health care brand, alongside the Old Spice male grooming range. The company was incorporated in 1964 as Richardson Hindustan Limited and became a subsidiary of the US-based Procter & Gamble Company in 1985. It earns by selling packaged sanitary-care, cough-and-cold, and personal-care products through retail and e-commerce channels across India.

Segments

  • Feminine Care
  • Health Care
Core brands
Whisper, Vicks, Old Spice
Business categories
Feminine Care and Health Care
Whisper market position
India's leading feminine hygiene brand
Vicks market position
India's No. 1 health care brand
Vicks product range
10+ SKUs (VapoRub, Cough Drops, Action 500 Advanced, Zzzquil, Inhaler, Xtra Strong Rub, Baby Rub, Steam Pods, Headache Roll-on, Cough Syrup)
Whisper product range
5 variants (Ultra, Choice, Ultra Skin Love, Flexfoam, Choice Nights)
Founded 1964Headquarters Mumbai, Maharashtra, India Company website

Guidance record · Q4 FY26

what the last two calls moved 3 tracked 1 delivered 1 missed 1 open
  • New User Acquisition & Problem Solving delivered said Q4 FY25 Promised: attract new users and help them more effectively tackle current and new jobs to be done Q4 FY26: Successfully established leadership in the new 'Period Panties' segment, selling 10 crore units in the last year. This demonstrates attracting users and solving new 'jobs to be done' through innovation.
  • Category Growth vs Industry Average missed said Q4 FY25 Promised: grow at a rate ahead of the industry average Q4 FY26: Company reported flat YoY sales growth (0%), while the Feminine Hygiene category grew at 7-10% and healthcare sub-categories grew at 2-3%. This did not meet the target of growing ahead of the industry average.
  • Sustained, Balanced Growth (Top-line and Bottom-line) open said Q4 FY26 Promised: inflect sustained, balanced growth Q4 FY26: Management expressed confidence that targeted investments in innovation and go-to-market capabilities will lead to sustained, balanced growth.

All 3 tracked — every revision, and every one management stopped mentioning.

Open the guidance ledger

Quarterly results

Q1 FY27: revenue down 4.9%, net profit down 34.4% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue1,135 1,248 992 937 1,150 +1%1,262 +1%941 −5%891 −5%
EBITDA290 371 210 266 285 −2%402 +8%218 +4%170 −36%
Net profit212 269 156 192 210 −1%301 +12%153 −2%126 −34%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance −43.3% 1Y

₹8k₹10k₹12k₹14kSept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Q4 FY26 — 16 Jun 2026

1Y: ₹13,255 on 10 Sept 2025 → ₹7,518. High ₹14,380 (6 Oct 2025), low ₹7,518 (11 Sept 2026).

How the price took the results

close before → close after

Q4 FY26
+0.9%
16 Jun

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Financials, as filed

Revenue grew 2.7% a year over 3 years, FY23 to FY26. Operating margin widened to 25.3%.

Year endingFY23FY24FY25FY26
Revenue₹3.9k Cr₹4.2k Cr₹4.3k Cr₹4.2k Cr
Operating profit₹868 Cr₹970 Cr₹1.1k Cr₹1.1k Cr
Operating margin22.2%23.1%26.4%25.3%
Interest₹12 Cr₹27 Cr₹15 Cr₹10 Cr
Depreciation₹58 Cr₹56 Cr₹41 Cr₹39 Cr
Net profit₹677 Cr₹675 Cr₹829 Cr₹790 Cr
Net margin17.3%16.1%19.2%18.6%
Cash from operations₹826 Cr₹470 Cr₹598 Cr₹924 Cr
Free cash flow₹781 Cr₹427 Cr₹544 Cr₹893 Cr
ROCE101.0%112.0%104.0%157.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹32 Cr₹32 Cr₹32 Cr₹32 Cr₹32 Cr₹32 Cr
Reserves₹682 Cr₹705 Cr₹914 Cr₹742 Cr₹899 Cr₹721 Cr
Borrowings₹3 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr₹1 Cr
Other liabilities₹915 Cr₹940 Cr₹1.2k Cr₹1.1k Cr₹1.2k Cr₹1.0k Cr
Total liabilities₹1.6k Cr₹1.7k Cr₹2.1k Cr₹1.9k Cr₹2.1k Cr₹1.8k Cr
Fixed assets₹184 Cr₹164 Cr₹170 Cr₹139 Cr₹166 Cr₹163 Cr
Capital work in progress₹38 Cr₹44 Cr₹23 Cr₹28 Cr₹14 Cr₹21 Cr
Investments₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Other assets₹1.4k Cr₹1.5k Cr₹1.9k Cr₹1.7k Cr₹2.0k Cr₹1.6k Cr
Total assets₹1.6k Cr₹1.7k Cr₹2.1k Cr₹1.9k Cr₹2.1k Cr₹1.8k Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, FIIs trimmed −0.40 pp while the public added +0.31 pp. The shareholder count grew 21% to 57,957.

Promoters
70.6%
FIIs
1.0%
DIIs
15.6%
Public
12.8%

Since Jun 2025

  • FIIs −0.40 pp
  • Public +0.31 pp
  • DIIs +0.09 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 70.6%, FIIs 1.3%, DIIs 15.4%, Public 12.6%.Dec '23: Promoters 70.6%, FIIs 1.5%, DIIs 15.3%, Public 12.6%.Mar '24: Promoters 70.6%, FIIs 1.6%, DIIs 15.1%, Public 12.7%.Jun '24: Promoters 70.6%, FIIs 1.6%, DIIs 15.2%, Public 12.7%.Sep '24: Promoters 70.6%, FIIs 1.5%, DIIs 15.3%, Public 12.6%.Dec '24: Promoters 70.6%, FIIs 1.4%, DIIs 15.4%, Public 12.6%.Mar '25: Promoters 70.6%, FIIs 1.3%, DIIs 15.5%, Public 12.5%.Jun '25: Promoters 70.6%, FIIs 1.4%, DIIs 15.5%, Public 12.5%.Sep '25: Promoters 70.6%, FIIs 1.1%, DIIs 16.1%, Public 12.2%.Dec '25: Promoters 70.6%, FIIs 1.1%, DIIs 16.0%, Public 12.3%.Mar '26: Promoters 70.6%, FIIs 1.0%, DIIs 16.0%, Public 12.4%.Jun '26: Promoters 70.6%, FIIs 1.0%, DIIs 15.6%, Public 12.8%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 2 holders trimming and 0 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Procter & Gamble Hygiene and Health Care Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Procter And Gamble Overseas India B.V. 68.73%unchanged
SBI Focused Fund Mutual fund5.06%unchanged
Life Insurance Corporation Of India Insurer4.07%unchanged
General Insurance Corporation Of India Insurer2.06%+0.31 pp
Procter & Gamble Home Products Private Limited 1.91%+1.91 pp
ICICI Prudential Large Cap Fund Mutual fund1.56%−0.24 pp
Temple Trees Impex And Investment Private Limited 0.00%−1.91 pp
Procter & Gamble Asia Pte. Ltd. 0.00%unchanged
Procter & Gamble Australia Proprietary Limited 0.00%unchanged
Procter & Gamble Azerbaijan Services LLC 0.00%unchanged
Procter & Gamble Bangladesh Private Ltd. 0.00%unchanged
Procter & Gamble Blois S.A.S. 0.00%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Mutual funds in PGHH

Filings to Aug 2026

0 new, 0 added, 0 trimmed, 0 sold out — net +0.00 L shares (+0.0%).

Held by funds
₹1.3k Cr
3 schemes
Biggest holder
SBI Focused Fund
₹718 Cr · 1.4% of that fund
SchemeHoldingLast month
SBI Focused Fund SBI Mutual Fund₹718 Crheld
SBI Aggressive Hybrid Fund SBI Mutual Fund₹343 Crheld
SBI Midcap Fund SBI Mutual Fund₹248 Crheld

HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.

Mutual funds Aug 2026

0 added, 0 trimmed — net 0 shares (+0.0%)

Funds are sitting on
-34%
vs est. average cost
Held by funds
₹1.3k Cr
3 schemes · ≈ 6.2% of the company
Biggest holder
SBI Focused Fund
₹718 Cr · 1.4% of that fund

Shares held by these funds −22%

Aug '23 16.41 L shares Jul '26

What the price assumes

Expensive

To justify its price of ₹7518, this stock must grow earnings at 21% every year for 7 years. Our analysis caps realistic growth at ~15%. At that growth it is worth ₹5504 — downside of 27%.

Growth the price implies
20.6% a year
for 7 years, fading to 4%
It has actually compounded at
14.6% a year
net profit, FY23–FY26 · EPS 14.6%
The gap
0.1 pp
-27% downside if it only repeats history
Price today ₹7,518 Value at the reference growth ₹5,503.51

Change the assumptions yourself →

All earnings calls (2)

Read the Q4 FY26 call →

Learn to analyse Procter & Gamble Hygiene and Health Care Limited

Guides on how to read this kind of business and the numbers that matter.